BioSpace News Archive

Akeso, Inc. announces that Ebronucimab, jointly developed by the Company and Dawnrays Biotechnology Capital Ltd., completed patient enrollment early in a pivotal registrational phase III clinical trial in the People’s Republic of China for the treatment of primary hypercholesterolemia and mixed hyperlipidemia.

Transparency Market Research has published a new report on the Soft tissue allografts market for the forecast period of 2019–2027.

The global self-care medical devices market is expanding at a CAGR of 7% within a forecast period from 2013 to 2019.

Ophthalmoscopes or also called direct ophthalmoscopes are hand-held optical instrument used to inspect not just fundus or back of the eye.

Medical copper tubing equipment is used for the supply of medical gas, which includes oxygen, carbon dioxide, nitrogen, and nitrous oxide.

Rising prevalence of various chronic and life threatening diseases is expected to drive the growth in the global anesthesia gas blenders market.

Envista Holdings Corporation (NYSE: NVST) (“Envista”) today announced it has entered into a definitive agreement to acquire Carestream Dental’s Intra-Oral Scanner (IOS) business for $600 million.

TandemAI today announced it has raised $25 million in Seed and pre-Series A financing to advance its proprietary computational platform and expansion of its wet lab operations.

- DURECT to receive near-term upfront cash payments totaling $6 million, potential additional milestone payments of up to $130 million and tiered low to mid double-digit royalties based on U.S. sales and Innocoll granted exclusive development and commercialization rights to POSIMIR in the United States.

AVEO Oncology today announced that members of its senior management team will participate in the H.C. Wainwright Virtual BioConnect 2022 Conference, which is taking place from Monday, January 10th to Thursday, January 13th.